يعرض 1 - 10 نتائج من 37 نتيجة بحث عن '"Matthew L. Ulrickson"', وقت الاستعلام: 1.22s تنقيح النتائج
  1. 1
    Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

    المؤلفون: Jason R. Westin, Frederick L. Locke, Michael Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David B. Miklos, Matthew L. Ulrickson, Miguel-Angel Perales, Umar Farooq, Luciano Wannesson, Lori Leslie, Marie José Kersten, Caron A. Jacobson, John M. Pagel, Gerald Wulf, Patrick Johnston, Aaron P. Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia T. Snider, Paul Cheng, Christina To, Olalekan O. Oluwole, Anna Sureda

    المصدر: Clinical Cancer Research. 29:1894-1905

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8f72b5d3a4e339746f686f1c93d7ff37Test
    https://doi.org/10.1158/1078-0432.ccr-22-3136Test


    أضف إلى المفضلة
  2. 2
    Supplementary Figure S5 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

    المؤلفون: Anna Sureda, Olalekan O. Oluwole, Christina To, Paul Cheng, Julia T. Snider, Jina Shah, Simone Filosto, Saran Vardhanabhuti, Linqiu Du, Aaron P. Rapoport, Patrick Johnston, Gerald Wulf, John M. Pagel, Caron A. Jacobson, Marie José Kersten, Lori Leslie, Luciano Wannesson, Umar Farooq, Miguel-Angel Perales, Matthew L. Ulrickson, David B. Miklos, Tom van Meerten, Mahmoud Elsawy, Armin Ghobadi, Michael Dickinson, Frederick L. Locke, Jason R. Westin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15d0cb50757effced27c720a6833dd16Test
    https://doi.org/10.1158/1078-0432.22820212Test


    أضف إلى المفضلة
  3. 3
    Supplementary Figure S2 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

    المؤلفون: Anna Sureda, Olalekan O. Oluwole, Christina To, Paul Cheng, Julia T. Snider, Jina Shah, Simone Filosto, Saran Vardhanabhuti, Linqiu Du, Aaron P. Rapoport, Patrick Johnston, Gerald Wulf, John M. Pagel, Caron A. Jacobson, Marie José Kersten, Lori Leslie, Luciano Wannesson, Umar Farooq, Miguel-Angel Perales, Matthew L. Ulrickson, David B. Miklos, Tom van Meerten, Mahmoud Elsawy, Armin Ghobadi, Michael Dickinson, Frederick L. Locke, Jason R. Westin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d431a63e585cb8a7450d3100f957cfeTest
    https://doi.org/10.1158/1078-0432.22820221.v1Test


    أضف إلى المفضلة
  4. 4
    Supplementary Figure S3 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

    المؤلفون: Anna Sureda, Olalekan O. Oluwole, Christina To, Paul Cheng, Julia T. Snider, Jina Shah, Simone Filosto, Saran Vardhanabhuti, Linqiu Du, Aaron P. Rapoport, Patrick Johnston, Gerald Wulf, John M. Pagel, Caron A. Jacobson, Marie José Kersten, Lori Leslie, Luciano Wannesson, Umar Farooq, Miguel-Angel Perales, Matthew L. Ulrickson, David B. Miklos, Tom van Meerten, Mahmoud Elsawy, Armin Ghobadi, Michael Dickinson, Frederick L. Locke, Jason R. Westin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ce675e990436e594988adac9dfcb80Test
    https://doi.org/10.1158/1078-0432.22820218Test


    أضف إلى المفضلة
  5. 5
    Low Incidence of Fungal Infections after Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma in an Endemic Region for Coccidioidomycosis

    المؤلفون: Charles Gaulin, Matthew L. Ulrickson, Muhammad Husnain, Madiha Iqbal, Paschalis Vergidis, Allison Rosenthal, Hemant Murthy, Carolyn Mead-Harvey, Yucai Wang, Januario E. Castro, Jeanne Palmer, Jose F. Leis, Patrick B. Johnston, Janis Blair, Mohamed A. Kharfan-Dabaja, Yi Lin, Javier Muñoz

    المصدر: Blood. 140:12111-12113

    مصطلحات موضوعية: Transplantation, Immunology, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology, Biochemistry

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d198960bf78f50b78e6c3c3e032fa43Test
    https://doi.org/10.1182/blood-2022-159744Test


    أضف إلى المفضلة
  6. 6
    Supplementary Figure S4 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

    المؤلفون: Anna Sureda, Olalekan O. Oluwole, Christina To, Paul Cheng, Julia T. Snider, Jina Shah, Simone Filosto, Saran Vardhanabhuti, Linqiu Du, Aaron P. Rapoport, Patrick Johnston, Gerald Wulf, John M. Pagel, Caron A. Jacobson, Marie José Kersten, Lori Leslie, Luciano Wannesson, Umar Farooq, Miguel-Angel Perales, Matthew L. Ulrickson, David B. Miklos, Tom van Meerten, Mahmoud Elsawy, Armin Ghobadi, Michael Dickinson, Frederick L. Locke, Jason R. Westin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c76856ffd5697757962a2c5ba7fb6f86Test
    https://doi.org/10.1158/1078-0432.22437820.v1Test


    أضف إلى المفضلة
  7. 7
    Supplementary Tables S1-S11 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

    المؤلفون: Anna Sureda, Olalekan O. Oluwole, Christina To, Paul Cheng, Julia T. Snider, Jina Shah, Simone Filosto, Saran Vardhanabhuti, Linqiu Du, Aaron P. Rapoport, Patrick Johnston, Gerald Wulf, John M. Pagel, Caron A. Jacobson, Marie José Kersten, Lori Leslie, Luciano Wannesson, Umar Farooq, Miguel-Angel Perales, Matthew L. Ulrickson, David B. Miklos, Tom van Meerten, Mahmoud Elsawy, Armin Ghobadi, Michael Dickinson, Frederick L. Locke, Jason R. Westin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed1d9c15fc59705979f1ad8b7246a1dTest
    https://doi.org/10.1158/1078-0432.22437814Test


    أضف إلى المفضلة
  8. 8
    Data from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

    المؤلفون: Anna Sureda, Olalekan O. Oluwole, Christina To, Paul Cheng, Julia T. Snider, Jina Shah, Simone Filosto, Saran Vardhanabhuti, Linqiu Du, Aaron P. Rapoport, Patrick Johnston, Gerald Wulf, John M. Pagel, Caron A. Jacobson, Marie José Kersten, Lori Leslie, Luciano Wannesson, Umar Farooq, Miguel-Angel Perales, Matthew L. Ulrickson, David B. Miklos, Tom van Meerten, Mahmoud Elsawy, Armin Ghobadi, Michael Dickinson, Frederick L. Locke, Jason R. Westin

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99248bd428e15e0023b1de66dc79af07Test
    https://doi.org/10.1158/1078-0432.c.6516061.v1Test


    أضف إلى المفضلة
  9. 9
    Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial

    المؤلفون: Sattva S. Neelapu, Michael Dickinson, Javier Munoz, Matthew L. Ulrickson, Catherine Thieblemont, Olalekan O. Oluwole, Alex F. Herrera, Chaitra S. Ujjani, Yi Lin, Peter A. Riedell, Natasha Kekre, Sven de Vos, Christine Lui, Francesca Milletti, Jinghui Dong, Hairong Xu, Julio C. Chavez

    المصدر: Nature Medicine. 28:735-742

    مصطلحات موضوعية: General Medicine, General Biochemistry, Genetics and Molecular Biology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::396493c32b74d3ba5218d617124e33e7Test
    https://doi.org/10.1038/s41591-022-01731-4Test


    أضف إلى المفضلة
  10. 10
    Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

    المؤلفون: Mahmoud Elsawy, Julio C. Chavez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob D. Rudzki, Saurabh Dahiya, Kathleen Dorritie, Samantha Jaglowski, John Radford, Franck Morschhauser, David Cunningham, Alejandro Martin Garcia-Sancho, Dimitrios Tzachanis, Matthew L. Ulrickson, Reem Karmali, Natasha Kekre, Catherine Thieblemont, Gunilla Enblad, Peter Dreger, Ram Malladi, Namita Joshi, Wei-Jhih Wang, Caitlyn T. Solem, Julia Thornton Snider, Paul Cheng, Christina To, Marie José Kersten

    المساهمون: Clinical Haematology, CCA - Cancer Treatment and Quality of Life

    المصدر: Blood, 140(21), 2248-2260. American Society of Hematology
    Elsawy, M, Chavez, J C, Avivi, I, Larouche, J-F, Wannesson, L, Cwynarski, K, Osman, K, Davison, K, Rudzki, J D, Dahiya, S, Dorritie, K A, Jaglowski, S M, Radford, J, Morschhauser, F, Cunningham, D, Martin Garcia-Sancho, A, Tzachanis, D, Ulrickson, M L, Karmali, R, Kekre, N, Thieblemont, C, Enblad, G, Dreger, P, Malladi, R, Joshi, N, Wang, W-J, Solem, C T, Snider, J T, Cheng, P, To, C & Kersten, M J 2022, ' Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma ', Blood . https://doi.org/10.1182/blood.2022015478Test

    مصطلحات موضوعية: Manchester Cancer Research Centre, ResearchInstitutes_Networks_Beacons/mcrc, Antigens, CD19, Immunology, Quality of Life, Humans, Lymphoma, Large B-Cell, Diffuse, Patient Reported Outcome Measures, Cell Biology, Hematology, Immunotherapy, Adoptive, Biochemistry

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::461f94cf5a147a9b936b0e8596bcfa87Test
    https://pure.amc.nl/en/publications/patientreported-outcomes-in-zuma7-a-phase-3-study-of-axicabtagene-ciloleucel-in-secondline-large-bcell-lymphomaTest(97d2d6dc-1bf2-4675-9ee8-a90efa10aa7d).html


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث